Heart Diseases: Molecular Mechanisms and New Therapies
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 20 November 2024 | Viewed by 22
Special Issue Editor
2. Women’s Health Research Institute, BC Women’s Hospital + Health Centre, H214 – 4500 Oak Street, Box 42B, Vancouver, BC V6H 3N1, Canada
3. Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
Interests: molecular basis of heart failure; molecular therapeutics; sex differences in cardiovascular health and disease; menopause
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit original research articles and reviews on the molecular mechanisms and novel therapies for heart diseases. Cardiovascular disease is a leading cause of death globally and its incidence is growing. Understanding the molecular changes that occur in the heart during the development of disease is critical to creating and applying novel therapies to treat heart diseases.
This Special Issue aims to highlight and promote our understanding of heart disease, including its molecular basis and emerging therapies to treat these conditions. Papers focused on a range of cardiac conditions, from genetic cardiomyopathies to ischemia-reperfusion injury, and stressors that impact heart function, from diabetes and hypertension to pregnancy and menopause, are welcomed. Furthermore, we invite studies that are fundamental in nature and use animal models of disease, alongside research involving patients and their care. The focus of studies and reviews should be identifying the molecular mechanisms of conditions that impact the heart and/or testing novel therapeutic strategies that mitigate dysfunction and injury.
I/We look forward to receiving your contributions.
Dr. Glen Pyle
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- heart disease
- myocardial
- molecular mechanisms
- therapies
